Royal Biologics, Inc.

NJ · United States · Reporting entity ID 100000291829

Total reported 2019–2025

$3.97M

#780 of 2,960 reporting companies — 0% of all reported industry payments

$1.79M in general payments across 2,518 records, plus $2.18M in research funding across 235 records.

How it breaks down

General payments $1,789,413

Research funding $2,180,120

Ownership & investment $1

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.